GlassScriptPhysician profile
Jason C Lee
NPI 1275717423
$2,519.43
in general payments reported to CMS, 2019-2025
18 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $186 · 2023: $849 · 2024: $637 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,019.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,151.84 | 2021-2025 | |
| Pfizer INC. | $357.02 | 2023-2025 | |
| Glaxosmithkline, LLC. | $315.69 | 2021-2023 | Shingrix, Arexvy |
| Amgen INC. | $158.00 | 2021-2023 | Evenity, Prolia, Tezspire |
| Abbvie INC. | $128.32 | 2021-2023 | |
| Teleflex LLC | $92.85 | 2023 | Urolift |
| Janssen Pharmaceuticals, INC | $57.92 | 2021-2022 | |
| Lilly USA, LLC | $51.64 | 2023 | Mounjaro, Jardiance |
| Abbott Laboratories | $37.72 | 2023 | Freestyle Libre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.14 | 2021-2024 | Ofev |
| Otsuka America Pharmaceutical, INC. | $23.67 | 2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $17.54 | 2024 | Quviviq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.51 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.90 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.81 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.18 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $14.61 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $13.07 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.